Cathy D Vocke Selected Research

Cathy D Vocke Research Topics

Disease

24	Neoplasms (Cancer) 04/2023 - 02/2002
12	Renal Cell Carcinoma (Grawitz Tumor) 04/2023 - 01/2010
8	Kidney Neoplasms (Kidney Cancer) 01/2021 - 05/2009
4	Carcinogenesis 01/2023 - 07/2012
3	Leiomyomatosis 01/2021 - 01/2010
2	Leiomyoma (Uterine Fibroids) 11/2023 - 01/2019
2	Disease Progression 01/2021 - 05/2009
1	Hereditary leiomyomatosis and renal cell cancer 11/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Cysts 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Familial renal cell carcinoma 01/2021
1	Hyperparathyroidism 2 01/2019
1	Hyperparathyroidism 01/2019
1	Hemorrhage 01/2019
1	Tuberous Sclerosis (Bourneville's Disease) 03/2017
1	sporadic Papillary renal cell carcinoma 01/2016
1	Oxyphilic Adenoma (Oncocytoma) 11/2015
1	Multiple Hamartoma Syndrome (Cowden's Disease) 12/2013
1	Cushing Syndrome 02/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2012
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 02/2011
1	Pheochromocytoma 02/2011
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 02/2011
1	Hypoxia (Hypoxemia) 05/2009
1	Carcinoma (Carcinomatosis) 06/2002

Drug/Important Bio-Agent (IBA)

8	Fumarate Hydratase (Fumarase)IBA 11/2023 - 01/2010
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2002
6	EnzymesIBA 01/2022 - 01/2010
6	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	FumaratesIBA 01/2021 - 12/2014
2	Microphthalmia-Associated Transcription FactorIBA 04/2023 - 01/2021
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2023 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2016
2	Mitochondrial DNA (mtDNA)IBA 01/2021 - 11/2015
2	Succinic Acid (Succinate)IBA 01/2021 - 01/2016
2	Tricarboxylic AcidsIBA 07/2012 - 01/2010
1	RNA Splice SitesIBA 11/2023
1	Sirolimus (Rapamycin)FDA Link 04/2023
1	mithramycin AIBA 04/2023
1	glembatumumab vedotinIBA 04/2023
1	8- (6- methoxypyridin- 3- yl)- 3- methyl- 1- (4- piperazin- 1- yl- 3- trifluoromethylphenyl)- 1,3- dihydroimidazo(4,5- c)quinolin- 2- oneIBA 04/2023
1	Immunoconjugates (Immunoconjugate)IBA 04/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	rilotumumabIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2022
1	SNX 2112IBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	alpha-hydroxyglutarateIBA 01/2021
1	Initiator Codon (Start Codon)IBA 01/2019
1	Dasatinib (BMS 354825)FDA Link 02/2018
1	trans-sodium crocetinate (crocetin)IBA 03/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	IsotopesIBA 01/2016
1	SulfurIBA 01/2016
1	Carbonic Anhydrase IXIBA 01/2016
1	IronIBA 01/2016
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 11/2015
1	MTOR InhibitorsIBA 12/2013
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2013
1	Epinephrine (Adrenaline)FDA LinkGeneric 02/2011
1	CatecholaminesIBA 02/2011
1	MetanephrineIBA 02/2011
1	Sorafenib (BAY 43-9006)FDA Link 05/2009
1	temsirolimus FDA Link 05/2009
1	Sunitinib (Sutent)FDA Link 05/2009
1	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2002

Therapy/Procedure

7	Therapeutics 04/2023 - 05/2009
1	Hysterectomy 01/2019
1	Lasers (Laser) 02/2002